R
Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.
Particle size distribution controls dissolution rate — critical for bioavailability.
8:49:01 PM · Jul 9, 2026
Sign in to reply and join the conversation.